Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 2
1995 2
1996 2
1997 1
1998 2
1999 2
2000 3
2004 2
2007 2
2009 3
2010 3
2011 7
2012 6
2013 2
2014 7
2015 5
2016 5
2017 10
2018 6
2019 7
2020 7
2021 9
2022 10
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation.
Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR. Farrell PM, et al. Among authors: mccolley sa. J Pediatr. 2017 Feb;181S:S4-S15.e1. doi: 10.1016/j.jpeds.2016.09.064. J Pediatr. 2017. PMID: 28129811 Free article.
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Wainwright CE, et al. Among authors: mccolley sa. N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25981758 Free PMC article. Clinical Trial.
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele.
Goralski JL, Hoppe JE, Mall MA, McColley SA, McKone E, Ramsey B, Rayment JH, Robinson P, Stehling F, Taylor-Cousar JL, Tullis E, Ahluwalia N, Chin A, Chu C, Lu M, Niu T, Weinstock T, Ratjen F, Rosenfeld M. Goralski JL, et al. Among authors: mccolley sa. Am J Respir Crit Care Med. 2023 Jul 1;208(1):59-67. doi: 10.1164/rccm.202301-0084OC. Am J Respir Crit Care Med. 2023. PMID: 36921081 Free PMC article.
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.
Zemanick ET, Taylor-Cousar JL, Davies J, Gibson RL, Mall MA, McKone EF, McNally P, Ramsey BW, Rayment JH, Rowe SM, Tullis E, Ahluwalia N, Chu C, Ho T, Moskowitz SM, Noel S, Tian S, Waltz D, Weinstock TG, Xuan F, Wainwright CE, McColley SA. Zemanick ET, et al. Among authors: mccolley sa. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1522-1532. doi: 10.1164/rccm.202102-0509OC. Am J Respir Crit Care Med. 2021. PMID: 33734030 Free PMC article. Clinical Trial.
This issue: pulmonology.
McColley SA. McColley SA. Pediatr Ann. 2010 Dec;39(12):742-4. doi: 10.3928/00904481-20101116-02. Pediatr Ann. 2010. PMID: 21162480 No abstract available.
Cystic fibrosis year in review 2017.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2018 Sep;53(9):1307-1317. doi: 10.1002/ppul.24081. Epub 2018 Jun 21. Pediatr Pulmonol. 2018. PMID: 29927544 Review.
Cystic fibrosis year in review 2016.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2017 Aug;52(8):1092-1102. doi: 10.1002/ppul.23747. Epub 2017 Jun 13. Pediatr Pulmonol. 2017. PMID: 28608632 Review.
Designing trials for new cystic fibrosis modulators.
Cunningham S, McColley SA. Cunningham S, et al. Among authors: mccolley sa. Lancet Respir Med. 2018 Jul;6(7):484-486. doi: 10.1016/S2213-2600(18)30195-4. Epub 2018 May 31. Lancet Respir Med. 2018. PMID: 29859920 Review. No abstract available.
The demographics of adverse outcomes in cystic fibrosis.
McGarry ME, Williams WA 2nd, McColley SA. McGarry ME, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2019 Nov;54 Suppl 3(Suppl 3):S74-S83. doi: 10.1002/ppul.24434. Pediatr Pulmonol. 2019. PMID: 31715087 Free PMC article. Review.
2014 year in review: Cystic fibrosis.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2015 Nov;50(11):1147-56. doi: 10.1002/ppul.23309. Epub 2015 Sep 7. Pediatr Pulmonol. 2015. PMID: 26347000 Review.
106 results